IVERIC bio, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€0.00 - Gross profit
€0.00 - SG&A expenses
€79.82M - R&D expenses
€117.78M - EBITDA
-€199.56M - D&A
-€1.93M - EBIT
-€197.60M - Interest expenses
€1.84M - EBT
-€192.27M - Tax expenses
-€9.29M - Net income
-€190.05M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€1.60M - Changes in working capital
€12.54M - Operating cash flow
-€152.55M - Capex
€735.79K - Other investing cash flow
€431.29K - Net investing cash flow
€19.96M - Total cash dividends paid
€0.00 - Issuance of common stock
€279.73M - Debt repayment
€0.00 - Other financing cash flow
€370.41M - Net financing cash flow
€370.41M - Foreign exchange effects
€0.00 - Net change in cash
€237.82M - Cash at end of period
€403.32M - Free cash flow
-€151.81M
Balance sheet
- Cash and cash equivalents
€403.32M - Cash and short-term investments
€517.49M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€10.03M - Total current assets
€527.51M - Property, plant & equipment
€1.61M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€1.61M - Total assets
€529.12M - Accounts payable
€15.55M - Short-term debt
€667.64K - Other current liabilities
€17.75M - Total current liabilities
€33.96M - Long-term debt
€83.66M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€83.66M - Total liabilities
€117.62M - Common stock
€118.17K - Retained earnings
-€808.28M - Other equity
-€85.40K - Total equity
€411.49M - Total liabilities and shareholders' equity
€529.12M
Company information
- Market capitalization
€4.70B - Employees
163 - Enterprise Value
€5.13B
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-46.2% Much better than peer group: -101.8% - ROA
-
-35.9% Better than peer group: -50.9% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-3.3% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€1.17M